$400,000 will fuel public-private collaboration to discover new disease biomarkers...
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...
Projects include important research on Parkinson’s, glioblastoma and dementia
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...
Academic and industry scientists collaborate on a new method to characterize research antibodies
Free, online training program strengthens training and brings specialized care to communities across Quebec...
Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy...
$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson’s disease...
Scientists argue the criteria we use for diagnosing autism may need revision...
RSS
